Brain Injury in Patients with Cardiac and Pulmonary Diseases
A special issue of Cells (ISSN 2073-4409).
Deadline for manuscript submissions: closed (31 March 2024) | Viewed by 255
Special Issue Editors
Interests: neurocritical care; brain injury; neurological outcome; stroke; ECMO; mechanical circulatory support device; ARDS
Interests: brain-lung crosstalk; ARDS; respiratory physiotherapy; tracheostomy/airways; microbiota
Special Issues, Collections and Topics in MDPI journals
Special Issue Information
Dear Colleagues,
In patients with lung diseases, a complex relationship between the brain and the lungs has been demonstrated by experimental and clinical studies over the past few decades. Even though acute brain injury is one of the most common complications in acute respiratory distress syndrome (ARDS) patients, the intricacy of the underlying pathophysiology of the observed crosstalk makes it difficult to fully understand. The brain of ARDS patients becomes extremely susceptible to developing secondary lung-mediated acute brain injury due to several pathophysiological factors, including hypoxemia, neurological adverse events of lung protective ventilation, hypotension, disruption of the blood–brain barrier, and neuroinflammation. A protective ventilator technique could limit or even stop the flow of further inflammatory mediators into the body, preserving brain homeostasis. Similar to patients with lung diseases, those with cardiovascular derangements are highly susceptible to acute brain injury. This Special Issue will include articles that investigate and review the close interaction between the heart and the brain and highlight the neurological complications of patients with cardiac diseases. In addition, this Special Issue highlights brain injury and cerebrovascular complications of patients with mechanical circulatory support devices.
The aim of this Special Issue is to publish papers on brain–lung and brain–heart interactions. We look forward to receiving review articles, brief reports, original research, preclinical experimental studies, narrative reviews, systematic reviews and meta-analyses.
Dr. Sung-Min Cho
Dr. Denise Battaglini
Guest Editors
Manuscript Submission Information
Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 100 words) can be sent to the Editorial Office for announcement on this website.
Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. Cells is an international peer-reviewed open access semimonthly journal published by MDPI.
Please visit the Instructions for Authors page before submitting a manuscript. The Article Processing Charge (APC) for publication in this open access journal is 2700 CHF (Swiss Francs). Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.
Keywords
- brain–lung crosstalk
- brain–heart crosstalk
- cerebrovascular complications
- mechanical circulatory support devices
- respiratory complications
- brain injury
- acute respiratory distress syndrome
- COVID-19
